Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
A biologic is manufactured in a living system such as a microorganism, or plant or animal cells. Most biologics are very large, complex molecules or mixtures of molecules. Many biologics are produced using recombinant DNA technology.
The report details the trend, potential and market size of Retinal Drugs and Biologics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Retinal Drugs and Biologicsmarket, defines the market attractiveness level of Retinal Drugs and Biologics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Retinal Drugs and Biologics industry, describes the types of Retinal Drugs and Biologics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Retinal Drugs and Biologics market and the development prospects and opportunities of Retinal Drugs and Biologics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Retinal Drugs and Biologics market in Chapter 13.
By Player:
Alimera Sciences
Genentech
ALLERGAN
OCULAR THERAPEUTIX
AbbVie
Swedish Orphan Biovitrum
Bristol-Myers Squibb
Janssen Biotech
UCBCares
Bausch & Lomb
Genzyme
Roche
By Type:
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Retinal Drugs and Biologics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Retinal Drugs and Biologics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Retinal Drugs and Biologics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Retinal Drugs and Biologics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Retinal Drugs and Biologics Market Analysis and Outlook to 2022
-
7.1 Global Retinal Drugs and Biologics Consumption (2017-2022)
-
7.2 United States Retinal Drugs and Biologics Consumption (2017-2022)
-
7.3 Europe Retinal Drugs and Biologics Consumption (2017-2022)
-
7.4 China Retinal Drugs and Biologics Consumption (2017-2022)
-
7.5 Japan Retinal Drugs and Biologics Consumption (2017-2022)
-
7.6 India Retinal Drugs and Biologics Consumption (2017-2022)
-
7.7 South Korea Retinal Drugs and Biologics Consumption (2017-2022)
8 Region and Country-wise Retinal Drugs and Biologics Market Analysis and Outlook to 2028
-
8.1 Global Retinal Drugs and Biologics Consumption Forecast (2022-2028)
-
8.2 United States Retinal Drugs and Biologics Consumption Forecast (2022-2028)
-
8.3 Europe Retinal Drugs and Biologics Consumption Forecast (2022-2028)
-
8.4 China Retinal Drugs and Biologics Consumption Forecast (2022-2028)
-
8.5 Japan Retinal Drugs and Biologics Consumption Forecast (2022-2028)
-
8.6 India Retinal Drugs and Biologics Consumption Forecast (2022-2028)
-
8.7 South Korea Retinal Drugs and Biologics Consumption Forecast (2022-2028)
9 Global Retinal Drugs and Biologics Market Outlook by Types and Applications to 2022
-
9.1 Global Retinal Drugs and Biologics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Age Related Macular Degeneration Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Diabetic Retinopathy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Ocular Inflammatory Disease (Uveitis) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Macular Hole Consumption and Growth Rate (2017-2022)
-
9.2 Global Retinal Drugs and Biologics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Retinal Drugs and Biologics Market Outlook by Types and Applications to 2028
-
10.1 Global Retinal Drugs and Biologics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Age Related Macular Degeneration Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Diabetic Retinopathy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Ocular Inflammatory Disease (Uveitis) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Macular Hole Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Retinal Drugs and Biologics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Retinal Drugs and Biologics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Retinal Drugs and Biologics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Retinal Drugs and Biologics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Retinal Drugs and Biologics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Retinal Drugs and Biologics Market Competitive Analysis
-
14.1 Alimera Sciences
-
14.1.1 Alimera Sciences Company Details
-
14.1.2 Alimera Sciences Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Alimera Sciences Retinal Drugs and Biologics Product and Service
-
14.2 Genentech
-
14.2.1 Genentech Company Details
-
14.2.2 Genentech Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Genentech Retinal Drugs and Biologics Product and Service
-
14.3 ALLERGAN
-
14.3.1 ALLERGAN Company Details
-
14.3.2 ALLERGAN Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 ALLERGAN Retinal Drugs and Biologics Product and Service
-
14.4 OCULAR THERAPEUTIX
-
14.4.1 OCULAR THERAPEUTIX Company Details
-
14.4.2 OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Product and Service
-
14.5 AbbVie
-
14.5.1 AbbVie Company Details
-
14.5.2 AbbVie Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AbbVie Retinal Drugs and Biologics Product and Service
-
14.6 Swedish Orphan Biovitrum
-
14.6.1 Swedish Orphan Biovitrum Company Details
-
14.6.2 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Product and Service
-
14.7 Bristol-Myers Squibb
-
14.7.1 Bristol-Myers Squibb Company Details
-
14.7.2 Bristol-Myers Squibb Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb Retinal Drugs and Biologics Product and Service
-
14.8 Janssen Biotech
-
14.8.1 Janssen Biotech Company Details
-
14.8.2 Janssen Biotech Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Janssen Biotech Retinal Drugs and Biologics Product and Service
-
14.9 UCBCares
-
14.9.1 UCBCares Company Details
-
14.9.2 UCBCares Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 UCBCares Retinal Drugs and Biologics Product and Service
-
14.10 Bausch & Lomb
-
14.10.1 Bausch & Lomb Company Details
-
14.10.2 Bausch & Lomb Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bausch & Lomb Retinal Drugs and Biologics Product and Service
-
14.11 Genzyme
-
14.11.1 Genzyme Company Details
-
14.11.2 Genzyme Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Genzyme Retinal Drugs and Biologics Product and Service
-
14.12 Roche
-
14.12.1 Roche Company Details
-
14.12.2 Roche Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Roche Retinal Drugs and Biologics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Retinal Drugs and Biologics
-
Figure Retinal Drugs and Biologics Picture
-
Table Global Retinal Drugs and Biologics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Retinal Drugs and Biologics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Retinal Drugs and Biologics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Retinal Drugs and Biologics Consumption by Country (2017-2022)
-
Figure United States Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)
-
Table Europe Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)
-
Figure China Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)
-
Figure Japan Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)
-
Figure India Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Retinal Drugs and Biologics Consumption and Growth Rate (2017-2022)
-
Figure Global Retinal Drugs and Biologics Consumption Forecast by Country (2022-2028)
-
Figure United States Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Retinal Drugs and Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Age Related Macular Degeneration Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetic Retinopathy Consumption and Growth Rate (2017-2022)
-
Figure Global Ocular Inflammatory Disease (Uveitis) Consumption and Growth Rate (2017-2022)
-
Figure Global Macular Hole Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Age Related Macular Degeneration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetic Retinopathy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ocular Inflammatory Disease (Uveitis) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Macular Hole Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Retinal Drugs and Biologics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Retinal Drugs and Biologics Export by Region (Top 5 Countries) (2017-2028)
-
Table Alimera Sciences (Foundation Year, Company Profile and etc.)
-
Table Alimera Sciences Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alimera Sciences Retinal Drugs and Biologics Product and Service
-
Table Genentech (Foundation Year, Company Profile and etc.)
-
Table Genentech Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Retinal Drugs and Biologics Product and Service
-
Table ALLERGAN (Foundation Year, Company Profile and etc.)
-
Table ALLERGAN Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table ALLERGAN Retinal Drugs and Biologics Product and Service
-
Table OCULAR THERAPEUTIX (Foundation Year, Company Profile and etc.)
-
Table OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table OCULAR THERAPEUTIX Retinal Drugs and Biologics Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Retinal Drugs and Biologics Product and Service
-
Table Swedish Orphan Biovitrum (Foundation Year, Company Profile and etc.)
-
Table Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Swedish Orphan Biovitrum Retinal Drugs and Biologics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Retinal Drugs and Biologics Product and Service
-
Table Janssen Biotech (Foundation Year, Company Profile and etc.)
-
Table Janssen Biotech Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Biotech Retinal Drugs and Biologics Product and Service
-
Table UCBCares (Foundation Year, Company Profile and etc.)
-
Table UCBCares Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCBCares Retinal Drugs and Biologics Product and Service
-
Table Bausch & Lomb (Foundation Year, Company Profile and etc.)
-
Table Bausch & Lomb Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bausch & Lomb Retinal Drugs and Biologics Product and Service
-
Table Genzyme (Foundation Year, Company Profile and etc.)
-
Table Genzyme Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genzyme Retinal Drugs and Biologics Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Retinal Drugs and Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Retinal Drugs and Biologics Product and Service
-
